Business ❯ Investing ❯ Securities

Investor Rights

Class Action Lawsuits CrowdStrike Holdings, Inc. Contingency Fee Arrangement Moderna, Inc. Class Action Lawsuit Replimune Group, Inc. Capricor Therapeutics, Inc.

ImmunityBio Faces Growing Securities Suits After FDA Flags Misleading Anktiva Claims

An FDA warning that promotional materials pushed unsupported cure‑all claims for Anktiva set off the investor actions.

ImmunityBio Sued in Securities Class Action Over Anktiva Marketing Claims

Unicycive Investors Urged to Seek Lead Role in Newly Filed Securities Class Action